Epidermal Growth Factor Receptor Clinical Trials

7 clinical trials for Epidermal Growth Factor Receptor across international registries, including 4 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• A Phase 1 Study of EPI-326 in EGFR-mutant NSCLC and HNSCC — RECRUITING · PHASE1
• Intrathecal Pemetrexed for Leptomeningeal Metastasis in EGFR-Mutant NSCLC — RECRUITING · PHASE2
• Bolstering Outcomes After Induction With Osimertinib Plus Chemotherapy Through Optimized Site-Directed Primary Tumor Therapy (BOOST Trial) — RECRUITING · PHASE2
• Biologic Association Between Metabolic Magnetic Resonance-positron Emission Tomograph (MR-PET) and Tissue Measures of Glycolysis in Brain Tumors of Infiltrating Glioblastoma Cells — RECRUITING · PHASE1
• Combination of Nimotuzumab and Radiotherapy for Recurrent Uterine Cervical Squamous Carcinoma — OTHER · PHASE2
• Rapid Plasma Genotyping For Early Initiation Of Erlotinib In EGFR Mutant Lung Cancer — TERMINATED · PHASE2
• Targeted Treatment With Intercalated Radiotherapy in EGFR-mutant IIIA/IIIB NSCLC — OTHER · PHASE2

Refine this search